Funding of the Development Program. (a) First-Time Pre-Clinical Development Activities. Alexion shall bear [*] percent ([*]%), and XOMA shall bear [*] percent ([*]%), of all Development Expenses incurred in conducting each activity set forth in the Initial Development Plan for the first Product to undergo such activity (collectively, the "First-Time Pre-Clinical Development Activities").
Appears in 3 contracts
Samples: Co Development and Co Commercialization Agreement (Alexion Pharmaceuticals Inc), Co Development and Co Commercialization Agreement (Xoma LTD /De/), Co Development and Co Commercialization Agreement (Xoma LTD /De/)
Funding of the Development Program. (a) First-Time Pre-Clinical Development Activities. Alexion shall bear [*] percent ([*]%), and XOMA shall bear [*] percent ([*]%), of all Development Expenses incurred in conducting each activity set forth in the Initial Development Plan for the first Product to undergo such activity (collectively, the "βFirst-Time Pre-Clinical Development Activities"β).
Appears in 2 contracts
Samples: Co Development and Co Commercialization Agreement, Co Development and Co Commercialization Agreement (Alexion Pharmaceuticals Inc)
